TrialPediatric research2025

Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in children aged 10-12 years: phase III randomized trial complementary analysis of immune persistence 3-6 years after priming.

James Peterson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.